Ulifloxacin(CAS: 112984-60-8)

Ulifloxacin (CAS: 112984-60-8) is regulated under the Globally Harmonized System of Classification and Labeling of Chemicals (GHS), REACH regulations, and FDA/EPA requirements for pharmaceutical and veterinary use. Manufacturers must comply with specific documentation, labeling, and safety data sheet (SDS) requirements to ensure safe handling and transport.

Ulifloxacin (CAS: 112984-60-8) can be synthesized using alternative reagents such as ciprofloxacin or norfloxacin. Isomers and analogs like moxifloxacin or levofloxacin are also considered alternatives in antimicrobial research and development, providing similar or enhanced efficacy in treating bacterial infections.

The market for Ulifloxacin (CAS: 112984-60-8) is declining due to its withdrawal from the market for human use. Research trends now focus on its use in veterinary applications, where it has shown potential in treating bacterial infections in livestock. Emerging studies also explore its antimicrobial properties against multi-drug resistant bacteria.

Waste containing Ulifloxacin (CAS: 112984-60-8) should be collected in sealed containers and disposed of through incineration or professional waste disposal services. Proper environmental protection precautions include wearing protective gear, ensuring the waste is not released into the environment, and following local and international regulations for hazardous waste management.